MarginsXMarginsX
Home › Markets › BFNH

Bioforce Nanosciences Holdings, Inc. (BFNH)

BFNH is quoted over the counter, not listed on an exchange. Bioforce Nanosciences Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$6.52
-6.5% on the day
1-year return
+986.7%
Market cap
$248.2M
Micro cap. From the Nov 16, 2026 close × 38.1M shares (10-Q cover page, Nov 6, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerBFNH, quoted over the counter
SEC CIK0001310488
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeLaboratory Analytical Instruments
Business addressVirginia Beach, VA

Warning signs

Cash runway
3.0 months
$32K cash at September 30, 2026
Share count, 1 year
+13.6%
2025-11-17 to 2026-11-06 · +30.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 9, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt as to the Company's ability to continue as a going concern."
10-Q 2026-11-09
Cash and burn$32K cash; operating cash flow -$31K a quarter.Report 2026-09-30
Shares outstanding38,065,914 (2026-11-06); 33,521,755 a year earlier; 29,271,755 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMICHAEL GILLESPIE & ASSOCIATES, PLLC, VANCOUVER, Washington, United StatesPCAOB Form AP 2026-04-15
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-13
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$342K-$95K$32KNo debt tagsNeeds four quarters10-Q 2026-11-09
Q2 2026
2026-06-30
Not filed$239K-$27K$307No debt tagsNeeds four quarters10-Q 2026-08-10
Q1 2026
2026-03-31
Not filed-$102K$7K$6KNo debt tagsNeeds four quarters10-Q 2026-05-19
Q4 2025
2025-12-31
Not filed-$118K-$11K$786No debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$116K-$11K$784No debt tagsNeeds four quarters10-Q 2026-11-09
Q2 2025
2025-06-30
Not filed-$123K-$28K$905No debt tagsNeeds four quarters10-Q 2026-08-10
Q1 2025
2025-03-31
Not filed-$935K-$15K$14KNo debt tagsNeeds four quarters10-Q 2026-05-19
Q4 2024
2024-12-31
Not filed-$123K-$15K$862No debt tagsNeeds four quarters10-K 2026-04-15

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32008-09-19
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-10-07
Latest proxyDEF 14A2008-04-14

Source: SEC EDGAR submissions feed, 254 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier